Science, Protein Engineering, Molecular Biology, Biochemistry, Virtual Reality.
presented on the company’s anti-SEMA4D research and data from its Phase 2 trial in Huntington’s Disease. In her presentation, “An Emerging Role for Glial Cells and Guidance Molecules in Neurodegeneration,” Dr. Evans’s explained the pathogenic role that the SEMA4D protein plays in neurodegeneration.